These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23959714)

  • 21. [Effectiveness and safety of natalizumab in multiple sclerosis: data of the first five years from the TOP (Tysabri Observational Program)].
    Magdolna S
    Ideggyogy Sz; 2014 May; 67(5-6):211-2. PubMed ID: 25087382
    [No Abstract]   [Full Text] [Related]  

  • 22. Atypical mycobacterial infection in a patient with hairy cell leukemia.
    Trizna Z; Tschen J; Natelson EA
    Cutis; 2001 Mar; 67(3):241-2. PubMed ID: 11270299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful management of Mycobacterium haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient.
    Baluch A; Pasikhova Y; Snyder M
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe anemia in a patient with multiple sclerosis treated with natalizumab.
    Simone AM; Ferraro D; Vitetta F; Marasca R; Bonacorsi G; Pinelli G; Federzoni L; Nichelli PF; Sola P
    Neurology; 2014 Jul; 83(4):374-5. PubMed ID: 24944259
    [No Abstract]   [Full Text] [Related]  

  • 25. [Infection due to Mycobacterium kansasii in Elche, Spain].
    Rodríguez JC; Ayelo A; Ruiz M; López M; Royo G
    Med Clin (Barc); 2003 Mar; 120(7):253-4. PubMed ID: 12623000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe haematological complications during treatment with natalizumab.
    Midaglia L; Rodriguez Ruiz M; Muñoz-García D
    Mult Scler; 2012 Nov; 18(11):1644-6. PubMed ID: 22438058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Respiratory infection by Mycobacterium mucogenicum].
    Requesens Solera M; Díaz Pollán B; Núñez Orantos MJ; Romero Calvo B
    Med Clin (Barc); 2014 Feb; 142(4):180-1. PubMed ID: 23683968
    [No Abstract]   [Full Text] [Related]  

  • 28. Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod.
    Behle V; Wobser M; Goebeler M; Stoevesandt J
    Mult Scler; 2016 Jun; 22(7):969-71. PubMed ID: 26860987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycobacterium kansasii osteomyelitis in a patient with AIDS on highly active antiretroviral therapy.
    Yano T; Okuda S; Kato K; Kato K; Kishimoto T
    Intern Med; 2004 Nov; 43(11):1084-6. PubMed ID: 15609709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lethal multiple sclerosis relapse after natalizumab withdrawal.
    Rigau V; Mania A; Béfort P; Carlander B; Jonquet O; Lassmann H; Camu W; Thouvenot E
    Neurology; 2012 Nov; 79(22):2214-6. PubMed ID: 23100404
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mycobacterium kansasii lung infection].
    Lemineur T; Bosquée L
    Rev Med Liege; 2015; 70(7-8):395-9. PubMed ID: 26376568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Journal club: Intrathecal effects of daclizumab treatment of multiple sclerosis.
    Schneider R; Arbour N
    Neurology; 2012 May; 78(22):e131-3. PubMed ID: 22641406
    [No Abstract]   [Full Text] [Related]  

  • 33. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.
    Segal BM; Constantinescu CS; Raychaudhuri A; Kim L; Fidelus-Gort R; Kasper LH;
    Lancet Neurol; 2008 Sep; 7(9):796-804. PubMed ID: 18703004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does chronic immunosuppressive therapy for autoimmune disease influence the risk of developing active tuberculosis?
    Bardazzi F; Leuzzi M; Ferrara F; Patrizi A; Loi C
    Dermatol Ther; 2019 Jan; 32(1):e12777. PubMed ID: 30371983
    [No Abstract]   [Full Text] [Related]  

  • 35. Mycobacterium kansasii infection in patients infected with the human immunodeficiency virus.
    Pintado V; Gómez-Mampaso E; Martín-Dávila P; Cobo J; Navas E; Quereda C; Fortún J; Guerrero A
    Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):582-6. PubMed ID: 10517196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe anemia in a patient with multiple sclerosis treated with natalizumab.
    Seibert JB; Alvarez E
    Neurology; 2015 Feb; 84(8):861. PubMed ID: 25713115
    [No Abstract]   [Full Text] [Related]  

  • 37. Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature.
    Han SH; Kim KM; Chin BS; Choi SH; Lee HS; Kim MS; Jeong SJ; Choi HK; Kim CO; Choi JY; Song YG; Kim JM
    J Korean Med Sci; 2010 Feb; 25(2):304-8. PubMed ID: 20119588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycobacterium kansasii.
    Johnston JC; Chiang L; Elwood K
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early onset of natalizumab-related progressive multifocal leukoencephalopathy.
    Damasceno A; von Glehn F; Martinez AR; Longhini AL; Deus-Silva L; Brandão CO; Santos LM; Damasceno BP
    Mult Scler; 2011 Nov; 17(11):1397-8. PubMed ID: 21900356
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pain, swelling, and progressive weakness of the left knee over 6 years].
    Pelfort X; Horcajada JP; Puig L; Salvadó M
    Enferm Infecc Microbiol Clin; 2008 Nov; 26(9):595-6. PubMed ID: 19100182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.